Epsilon Healthcare Limited (ASX:EPN)

Market Cap	8.95M +49.0%
Revenue (ttm)	9.39M +67.7%
Net Income	-1.28M
EPS	-0.00
Shares Out	389.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,738
Open	0.0230
Previous Close	0.0230
Day's Range	0.0230 - 0.0240
52-Week Range	0.0190 - 0.0400
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Epsilon Healthcare

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EPN

Financial Performance

In 2025, Epsilon Healthcare's revenue was 9.39 million, an increase of 67.74% compared to the previous year's 5.60 million. Losses were -1.28 million, -76.73% less than in 2024.